N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide

C110H122N34O20 — CID 158029790

IUPACN-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide
SMILESCOc1cc2c(cc1OC)C(=O)N(c1nnc(C(=O)Nc3cnccc3N(C)CCN)o1)C2.COc1cc2c(cc1OC)C(=O)N(c1nnc(C(=O)Nc3cnccc3OCCN)o1)C2.COc1cccc(C2CCN(c3nnc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2)c1.COc1cccc(C2CCN(c3nnc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2=O)c1.O=C(Nc1cnccc1N1CCNCC1)c1nnc(N2CCC(c3ccccc3)CC2)o1
InChIInChI=1S/C23H25N7O4.C23H27N7O3.C23H27N7O2.C21H23N7O5.C20H20N6O6/c1-33-16-4-2-3-15(13-16)17-6-10-30(22(17)32)23-28-27-21(34-23)20(31)26-18-14-25-7-5-19(18)29-11-8-24-9-12-29;1-32-18-4-2-3-16(13-18)17-6-10-30(15-17)23-28-27-22(33-23)21(31)26-19-14-25-7-5-20(19)29-11-8-24-9-12-29;31-21(26-19-16-25-9-6-20(19)29-14-10-24-11-15-29)22-27-28-23(32-22)30-12-7-18(8-13-30)17-4-2-1-3-5-17;1-27(7-5-22)15-4-6-23-10-14(15)24-18(29)19-25-26-21(33-19)28-11-12-8-16(31-2)17(32-3)9-13(12)20(28)30;1-29-15-7-11-10-26(19(28)12(11)8-16(15)30-2)20-25-24-18(32-20)17(27)23-13-9-22-5-3-14(13)31-6-4-21/h2-5,7,13-14,17,24H,6,8-12H2,1H3,(H,26,31);2-5,7,13-14,17,24H,6,8-12,15H2,1H3,(H,26,31);1-6,9,16,18,24H,7-8,10-15H2,(H,26,31);4,6,8-10H,5,7,11,22H2,1-3H3,(H,24,29);3,5,7-9H,4,6,10,21H2,1-2H3,(H,23,27)
InChIKeyFHAUOODAYUAWNP-UHFFFAOYSA-N
MW2240.40 g/mol
LogP8.82
Rot. Bonds33

About N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide

N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide (PubChem CID 158029790) has the molecular formula C110H122N34O20 and a molecular weight of 2240.40 g/mol. Its IUPAC name is N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide.

Molecular Properties

Compound NameN-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide
PubChem CID158029790
Molecular FormulaC110H122N34O20
Molecular Weight2240.40 g/mol
Exact Mass2238.96
IUPAC NameN-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide
SMILESCOc1cc2c(cc1OC)C(=O)N(c1nnc(C(=O)Nc3cnccc3N(C)CCN)o1)C2.COc1cc2c(cc1OC)C(=O)N(c1nnc(C(=O)Nc3cnccc3OCCN)o1)C2.COc1cccc(C2CCN(c3nnc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2)c1.COc1cccc(C2CCN(c3nnc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2=O)c1.O=C(Nc1cnccc1N1CCNCC1)c1nnc(N2CCC(c3ccccc3)CC2)o1
InChIInChI=1S/C23H25N7O4.C23H27N7O3.C23H27N7O2.C21H23N7O5.C20H20N6O6/c1-33-16-4-2-3-15(13-16)17-6-10-30(22(17)32)23-28-27-21(34-23)20(31)26-18-14-25-7-5-19(18)29-11-8-24-9-12-29;1-32-18-4-2-3-16(13-18)17-6-10-30(15-17)23-28-27-22(33-23)21(31)26-19-14-25-7-5-20(19)29-11-8-24-9-12-29;31-21(26-19-16-25-9-6-20(19)29-14-10-24-11-15-29)22-27-28-23(32-22)30-12-7-18(8-13-30)17-4-2-1-3-5-17;1-27(7-5-22)15-4-6-23-10-14(15)24-18(29)19-25-26-21(33-19)28-11-12-8-16(31-2)17(32-3)9-13(12)20(28)30;1-29-15-7-11-10-26(19(28)12(11)8-16(15)30-2)20-25-24-18(32-20)17(27)23-13-9-22-5-3-14(13)31-6-4-21/h2-5,7,13-14,17,24H,6,8-12H2,1H3,(H,26,31);2-5,7,13-14,17,24H,6,8-12,15H2,1H3,(H,26,31);1-6,9,16,18,24H,7-8,10-15H2,(H,26,31);4,6,8-10H,5,7,11,22H2,1-3H3,(H,24,29);3,5,7-9H,4,6,10,21H2,1-2H3,(H,23,27)
InChIKeyFHAUOODAYUAWNP-UHFFFAOYSA-N
XLogP8.82
TPSA637.66 Ų
H-Bond Donors10
H-Bond Acceptors46
Rotatable Bonds33
Heavy Atoms164
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002240.40
LogP ≤ 58.82
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1046

Analyze N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide?
The IUPAC name of N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide (CID 158029790) is N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide.
What is the SMILES notation for N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide?
The canonical SMILES for N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide is COc1cc2c(cc1OC)C(=O)N(c1nnc(C(=O)Nc3cnccc3N(C)CCN)o1)C2.COc1cc2c(cc1OC)C(=O)N(c1nnc(C(=O)Nc3cnccc3OCCN)o1)C2.COc1cccc(C2CCN(c3nnc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2)c1.COc1cccc(C2CCN(c3nnc(C(=O)Nc4cnccc4N4CCNCC4)o3)C2=O)c1.O=C(Nc1cnccc1N1CCNCC1)c1nnc(N2CCC(c3ccccc3)CC2)o1.
What is the InChIKey of N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide?
The InChIKey is FHAUOODAYUAWNP-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H25N7O4.C23H27N7O3.C23H27N7O2.C21H23N7O5.C20H20N6O6/c1-33-16-4-2-3-15(13-16)17-6-10-30(22(17)32)23-28-27-21(34-23)20(31)26-18-14-25-7-5-19(18)29-11-8-24-9-12-29;1-32-18-4-2-3-16(13-18)17-6-10-30(15-17)23-28-27-22(33-23)21(31)26-19-14-25-7-5-20(19)29-11-8-24-9-12-29;31-21(26-19-16-25-9-6-20(19)29-14-10-24-11-15-29)22-27-28-23(32-22)30-12-7-18(8-13-30)17-4-2-1-3-5-17;1-27(7-5-22)15-4-6-23-10-14(15)24-18(29)19-25-26-21(33-19)28-11-12-8-16(31-2)17(32-3)9-13(12)20(28)30;1-29-15-7-11-10-26(19(28)12(11)8-16(15)30-2)20-25-24-18(32-20)17(27)23-13-9-22-5-3-14(13)31-6-4-21/h2-5,7,13-14,17,24H,6,8-12H2,1H3,(H,26,31);2-5,7,13-14,17,24H,6,8-12,15H2,1H3,(H,26,31);1-6,9,16,18,24H,7-8,10-15H2,(H,26,31);4,6,8-10H,5,7,11,22H2,1-3H3,(H,24,29);3,5,7-9H,4,6,10,21H2,1-2H3,(H,23,27).
What are the key properties of N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide?
N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide has a molecular weight of 2240.40 g/mol, XLogP of 8.82, 33 rotatable bonds, 10 hydrogen bond donors, and 46 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(2-aminoethoxy)-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;N-[4-[2-aminoethyl(methyl)amino]-3-pyridinyl]-5-(5,6-dimethoxy-3-oxo-1H-isoindol-2-yl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)-2-oxopyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-[3-(3-methoxyphenyl)pyrrolidin-1-yl]-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide;5-(4-phenylpiperidin-1-yl)-N-(4-piperazin-1-yl-3-pyridinyl)-1,3,4-oxadiazole-2-carboxamide is sourced from PubChem (CID 158029790), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).